{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T15:21:11Z","timestamp":1791300071273,"version":"4.1.0"},"reference-count":56,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuroscience & Biobehavioral Reviews"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1016\/j.neubiorev.2012.10.014","type":"journal-article","created":{"date-parts":[[2012,11,5]],"date-time":"2012-11-05T22:40:26Z","timestamp":1352155226000},"page":"1157-1161","source":"Crossref","is-referenced-by-count":44,"title":["Pharmacological treatment of Gilles de la Tourette syndrome"],"prefix":"10.1016","volume":"37","author":[{"given":"Andreas","family":"Hartmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulia","family":"Worbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neubiorev.2012.10.014_bib0005","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1176\/appi.ajp.158.6.968","article-title":"Control of Tourette's syndrome with topiramate","volume":"158","author":"Abuzzahab","year":"2001","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.neubiorev.2012.10.014_bib0010","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1097\/CHI.0b013e3181b26e9f","article-title":"Meta-analysis: treatment of attention-deficit\/hyperactivity disorder in children with comorbid tic disorders","volume":"48","author":"Bloch","year":"2009","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"key":"10.1016\/j.neubiorev.2012.10.014_bib0015","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1192\/bjp.105.441.1078","article-title":"Gilles de la Tourette's disease","volume":"105","author":"Bockner","year":"1959","journal-title":"Journal of Mental Science"},{"key":"10.1016\/j.neubiorev.2012.10.014_bib0020","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1089\/cap.2007.061","article-title":"Aripiprazole in children and adolescents with Tourette disorder with and without explosive outbursts","volume":"18","author":"Budman","year":"2008","journal-title":"Journal of Child and Adolescent Psychopharmacology"},{"key":"10.1016\/j.neubiorev.2012.10.014_bib0025","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1212\/01.wnl.0000327890.02893.61","article-title":"The Gilles de la Tourette syndrome-quality of life scale (GTS-QOL): development and validation","volume":"71","author":"Cavanna","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.neubiorev.2012.10.014_bib0030","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1176\/jnp.2009.21.1.13","article-title":"The behavioral spectrum of Gilles de la Tourette syndrome","volume":"21","author":"Cavanna","year":"2009","journal-title":"Journal of Neuropsychiatry and Clinical Neurosciences"},{"key":"10.1016\/j.neubiorev.2012.10.014_bib0035","series-title":"Treating Tourette Syndrome and Tic Disorders","first-page":"85","article-title":"Neurocognitive factors in Tourette syndrome","author":"Chang","year":"2007"},{"key":"10.1016\/j.neubiorev.2012.10.014_bib0040","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1002\/mds.21599","article-title":"Malignant Tourette syndrome","volume":"22","author":"Cheung","year":"2007","journal-title":"Movement Disorders"},{"key":"10.1016\/j.neubiorev.2012.10.014_bib0045","doi-asserted-by":"crossref","first-page":"e2632","DOI":"10.1371\/journal.pone.0002632","article-title":"Are child and adolescent responses to placebo higher in major depression than in anxiety disorders? A systematic review of placebo-controlled trials","volume":"3","author":"Cohen","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.neubiorev.2012.10.014_bib0050","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1097\/YCO.0b013e3282f53132","article-title":"Tardive dyskinesia and new antipsychotics","volume":"21","author":"Correll","year":"2008","journal-title":"Current Opinion in Psychiatry"},{"key":"10.1016\/j.neubiorev.2012.10.014_bib0055","doi-asserted-by":"crossref","first-page":"155","DOI":"10.2165\/11208400-000000000-00000","article-title":"Aripiprazole: a review of its use in the management of schizophrenia in adults","volume":"26","author":"Croxtall","year":"2012","journal-title":"CNS Drugs"},{"key":"10.1016\/j.neubiorev.2012.10.014_bib0060","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1002\/hup.798","article-title":"A case series of patients with Tourette's syndrome in the United Kingdom treated with aripiprazole","volume":"21","author":"Davies","year":"2006","journal-title":"Human Psychopharmacology"},{"key":"10.1016\/j.neubiorev.2012.10.014_bib0065","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1212\/01.WNL.0000064285.98285.CF","article-title":"Cervical myelopathy secondary to violent tics of Tourette's syndrome","volume":"60","author":"Dobbs","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.neubiorev.2012.10.014_bib0070","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1056\/NEJMoa0907006","article-title":"L-histidine decarboxylase and Tourette's syndrome","volume":"362","author":"Ercan-Sencicek","year":"2010","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.neubiorev.2012.10.014_bib0075","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.biopsych.2011.09.034","article-title":"Rare copy number variants in tourette syndrome disrupt genes in histaminergic pathways and overlap with autism","volume":"71","author":"Fernandez","year":"2012","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.neubiorev.2012.10.014_bib0080","series-title":"Treating Tourette Syndrome and Tic Disorders","first-page":"225","article-title":"Management of familial issues in persons with Tourette syndrome","author":"Ginsburg","year":"2007"},{"key":"10.1016\/j.neubiorev.2012.10.014_bib0085","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/ana.410210313","article-title":"Clonidine and Gilles de la Tourette's syndrome: double-blind study using objective rating methods","volume":"21","author":"Goetz","year":"1987","journal-title":"Annals of Neurology"},{"key":"10.1016\/j.neubiorev.2012.10.014_bib0090","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1017\/S0317167100025129","article-title":"Seven cases of Gilles de la Tourette's syndrome: partial relief with clonazepam: a pilot study","volume":"4","author":"Gonce","year":"1977","journal-title":"Canadian Journal of Neurological Sciences"},{"key":"10.1016\/j.neubiorev.2012.10.014_bib0095","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s00415-011-6171-1","article-title":"Increasing histamine neurotransmission in Gilles de la Tourette syndrome","volume":"259","author":"Hartmann","year":"2012","journal-title":"Journal of Neurology"},{"key":"10.1016\/j.neubiorev.2012.10.014_bib0100","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.pediatrneurol.2008.12.014","article-title":"Double-blind, crossover study of clonidine and levetiracetam in Tourette syndrome","volume":"40","author":"Hedderick","year":"2009","journal-title":"Pediatric Neurology"},{"key":"10.1016\/j.neubiorev.2012.10.014_bib0105","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2147\/NDT.S12990","article-title":"Update on the role of antipsychotics in the treatment of Tourette syndrome","volume":"8","author":"Huys","year":"2012","journal-title":"Neuropsychiatric Disease and Treatment"},{"key":"10.1016\/j.neubiorev.2012.10.014_bib0110","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1136\/jnnp.2009.185348","article-title":"A randomised, double-blind, placebo-controlled study of topiramate in the treatment of Tourette syndrome","volume":"81","author":"Jankovic","year":"2010","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"key":"10.1016\/j.neubiorev.2012.10.014_bib0115","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1002\/mds.23618","article-title":"Tourette syndrome: evolving concepts","volume":"26","author":"Jankovic","year":"2011","journal-title":"Movement Disorders"},{"key":"10.1016\/j.neubiorev.2012.10.014_bib0120","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1002\/mds.23957","article-title":"Treatment of tics in patients with Tourette syndrome: recommendations according to the European Society for the Study of Tourette Syndrome (author reply)","volume":"26","author":"Jankovic","year":"2011","journal-title":"Movement Disorders"},{"key":"10.1016\/j.neubiorev.2012.10.014_bib0125","series-title":"Treating Tourette Syndrome and Tic Disorders","first-page":"242","article-title":"Management of learning and school difficulties in children with Tourette syndrome","author":"Kepley","year":"2007"},{"key":"10.1016\/j.neubiorev.2012.10.014_bib0130","series-title":"A Cursing Brain? The Histories of Tourette Syndrome","author":"Kushner","year":"1999"},{"key":"10.1016\/j.neubiorev.2012.10.014_bib0135","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1001\/archneur.57.8.1190","article-title":"Botulinum toxin in the treatment of tics","volume":"57","author":"Kwak","year":"2000","journal-title":"Archives of Neurology"},{"key":"10.1016\/j.neubiorev.2012.10.014_bib0140","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1212\/WNL.0b013e318238253c","article-title":"Vertebral artery dissection leading to stroke caused by violent neck tics of Tourette syndrome","volume":"77","author":"Lehman","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.neubiorev.2012.10.014_bib0145","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1089\/cap.2009.0035","article-title":"Aripiprazole in children and adolescents with Tourette's disorder: an open-label safety and tolerability study","volume":"19","author":"Lyon","year":"2009","journal-title":"Journal of Child and Adolescent Psychopharmacology"},{"key":"10.1016\/j.neubiorev.2012.10.014_bib0150","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1212\/WNL.56.5.605","article-title":"Botulinum toxin for simple motor tics: a randomized, double-blind, controlled clinical trial","volume":"56","author":"Marras","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.neubiorev.2012.10.014_bib0155","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1002\/mds.23958","article-title":"European Society for the Study of Tourette Syndrome: treatment of tics in patients with Tourette syndrome: recommendations according to the European Society for the Study of Tourette Syndrome","volume":"26","author":"M\u00fcller-Vahl","year":"2011","journal-title":"Movement Disorders"},{"key":"10.1016\/j.neubiorev.2012.10.014_bib0160","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1002\/mds.23894","article-title":"Does Tourette syndrome prevent tardive dyskinesia?","volume":"26","author":"M\u00fcller-Vahl","year":"2011","journal-title":"Movement Disorders"},{"key":"10.1016\/j.neubiorev.2012.10.014_bib0165","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1517\/14656566.4.10.1717","article-title":"Cannabinoids reduce symptoms of Tourette's syndrome","volume":"4","author":"M\u00fcller-Vahl","year":"2003","journal-title":"Expert Opinion on Pharmacotherapy"},{"issue":"August (4)","key":"10.1016\/j.neubiorev.2012.10.014_bib0275","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1089\/cap.2008.0149","article-title":"Open label aripiprazole in the treatment of youth with tic disorders","volume":"19","author":"Murphy","year":"2009","journal-title":"Child and Adolescent Psychopharmacology"},{"issue":"June","key":"10.1016\/j.neubiorev.2012.10.014_bib0170","article-title":"Effectiveness of aripiprazole in the treatment of adult Tourette patients up to 56 months","author":"Neuner","year":"2012","journal-title":"Human Psychopharmacology"},{"key":"10.1016\/j.neubiorev.2012.10.014_bib0175","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1089\/cap.2010.0027","article-title":"An overview of the treatment of Tourette's disorder and tics","volume":"20","author":"P\u00e1rraga","year":"2010","journal-title":"Journal of Child and Adolescent Psychopharmacology"},{"key":"10.1016\/j.neubiorev.2012.10.014_bib0180","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1007\/s10072-003-0201-4","article-title":"Treatment of phonic tics in patients with Tourette's syndrome using botulinum toxin type A","volume":"24","author":"Porta","year":"2004","journal-title":"Neurological Sciences"},{"issue":"7","key":"10.1016\/j.neubiorev.2012.10.014_bib0280","doi-asserted-by":"crossref","first-page":"443","DOI":"10.2165\/00044011-200828070-00006","article-title":"Tourette's syndrome and role of tetrabenazine: review and personal experience","volume":"28","author":"Porta","year":"2008","journal-title":"Clinical Drug Investigation"},{"key":"10.1016\/j.neubiorev.2012.10.014_bib0185","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1089\/1044546041649084","article-title":"Guanfacine treatment of hyperactivity and inattention in pervasive developmental disorders: a retrospective analysis of 80 cases","volume":"14","author":"Posey","year":"2004","journal-title":"Journal of Child and Adolescent Psychopharmacology"},{"issue":"April (2)","key":"10.1016\/j.neubiorev.2012.10.014_bib0190","first-page":"CD006996","article-title":"Pimozide for tics in Tourette's syndrome","author":"Pringsheim","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1016\/j.neubiorev.2012.10.014_bib0195","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1177\/070674371205700302","article-title":"Canadian guidelines for the evidence-based treatment of tic disorders: pharmacotherapy","volume":"57","author":"Pringsheim","year":"2012","journal-title":"Canadian Journal of Psychiatry"},{"key":"10.1016\/j.neubiorev.2012.10.014_bib0200","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.jpsychores.2008.03.006","article-title":"The prevalence and epidemiology of Gilles de la Tourette syndrome. Part 1: The epidemiological and prevalence studies","volume":"65","author":"Robertson","year":"2008","journal-title":"Journal of Psychosomatic Research"},{"key":"10.1016\/j.neubiorev.2012.10.014_bib0205","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s00787-011-0163-7","article-title":"European clinical guidelines for Tourette syndrome and other tic disorders. Part II: Pharmacological treatment","volume":"20","author":"Roessner","year":"2011","journal-title":"European Child and Adolescent Psychiatry"},{"key":"10.1016\/j.neubiorev.2012.10.014_bib0210","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1176\/appi.ajp.158.7.1067","article-title":"A placebo-controlled study of guanfacine in the treatment of children with tic disorders and attention deficit hyperactivity disorder","volume":"158","author":"Scahill","year":"2001","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.neubiorev.2012.10.014_bib0215","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.nurx.2006.01.009","article-title":"Contemporary assessment and pharmacotherapy of Tourette syndrome","volume":"3","author":"Scahill","year":"2006","journal-title":"NeuroRx"},{"issue":"April (7)","key":"10.1016\/j.neubiorev.2012.10.014_bib0220","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1212\/01.WNL.0000055434.39968.67","article-title":"A placebo-controlled trial of risperidone in Tourette syndrome","volume":"60","author":"Scahill","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.neubiorev.2012.10.014_bib0225","first-page":"578","article-title":"Un cas de maladie des tics de Gilles de la Tourette gu\u00e9ri par le R.1625","volume":"119","author":"Seignot","year":"1961","journal-title":"Annales M\u00e9dico-Psychologiques"},{"key":"10.1016\/j.neubiorev.2012.10.014_bib0230","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1089\/cap.2007.0064","article-title":"Aripiprazole treatment of children and adolescents with Tourette disorder or chronic tic disorder","volume":"18","author":"Seo","year":"2008","journal-title":"Journal of Child and Adolescent Psychopharmacology"},{"key":"10.1016\/j.neubiorev.2012.10.014_bib0235","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1192\/bjp.114.508.345","article-title":"Treatment of Gilles de la Tourette's syndrome with haloperidol","volume":"114","author":"Shapiro","year":"1968","journal-title":"British Journal of Psychiatry"},{"key":"10.1016\/j.neubiorev.2012.10.014_bib0240","doi-asserted-by":"crossref","first-page":"707","DOI":"10.4088\/JCP.v62n0908","article-title":"Transdermal nicotine and haloperidol in Tourette's disorder: a double-blind placebo-controlled study","volume":"62","author":"Silver","year":"2001","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1016\/j.neubiorev.2012.10.014_bib0245","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1212\/WNL.56.5.599","article-title":"Baclofen treatment in Tourette syndrome: a double-blind, placebo-controlled, crossover trial","volume":"56","author":"Singer","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.neubiorev.2012.10.014_bib0250","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s11940-010-0095-4","article-title":"Treatment of tics and Tourette syndrome","volume":"12","author":"Singer","year":"2010","journal-title":"Current Treatment Options in Neurology"},{"key":"10.1016\/j.neubiorev.2012.10.014_bib0255","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1097\/chi.0b013e318068fbcc","article-title":"Tourette syndrome and tic disorders: a decade of progress","volume":"46","author":"Swain","year":"2007","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"key":"10.1016\/j.neubiorev.2012.10.014_bib0260","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1002\/mds.23521","article-title":"Motor tic of the neck: a probable cause of stroke in a child with Gilles de la Tourette syndrome","volume":"26","author":"Van Meerbeeck","year":"2011","journal-title":"Movement Disorders"},{"issue":"June","key":"10.1016\/j.neubiorev.2012.10.014_bib0265","article-title":"Aripiprazole for the treatment of Tourette syndrome: a case series of 100 patients","author":"Wenzel","year":"2012","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1016\/j.neubiorev.2012.10.014_bib0270","series-title":"Treating Tourette Syndrome and Tic Disorders","first-page":"22","article-title":"Assessment of tic disorders","author":"Woods","year":"2007"}],"container-title":["Neuroscience & Biobehavioral Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149763412001819?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149763412001819?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,5]],"date-time":"2019-07-05T08:22:24Z","timestamp":1562314944000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149763412001819"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":56,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["S0149763412001819"],"URL":"https:\/\/doi.org\/10.1016\/j.neubiorev.2012.10.014","relation":{},"ISSN":["0149-7634"],"issn-type":[{"value":"0149-7634","type":"print"}],"subject":[],"published":{"date-parts":[[2013,7]]}}}